Introduction
Preeclampsia and eclampsia are conditions with unknown pathogenesis seen in 1-10% of all pregnancies and characterized by the manifestation of hypertension, proteinuria, and/or edema. Major risk factors regarding these conditions are known as preterm birth and developmental delay [1] .
As a result of damaged trophoblastic invasion of the maternal vessels, mediators that join circulation due to decreased placental perfusion damage the endothelial cells and disrupt their functions. This situation is considered to be the main reason for this clinical condition [2] .
It has been known for a long time that increase in platelet volume is an indicator of increased platelet synthesis [3, 4] . In normal pregnancies, compensated with increased synthesis and increased platelet volume, an increase in the platelet aggregation has been detected [5] . In the evaluation of the platelet functions during a normal pregnancy, the sensitivity of the variations in the platelet volume was found to be higher than variations in the platelet number [6] .
Main pathophysiological events in preeclampsia are changes in blood circulation, endothelial cell damage, platelet activation, and increased intravenous thrombin formation [7] . Moreover, there are also published data showing the changes in platelet number, volume, and function and this is related to the activation in maternal vessel system [8, 9] .
In preeclampsia, neonatal neutropenia and thrombocytopenia are commonly seen and the reason behind this is still unknown, but, it is claimed that this is due to decreased leukocyte and platelet production caused by placental deficiency [10] [11] [12] . Early thrombocytopenia seen in babies of preeclamptic mothers is especially seen in placental deficiency caused by hypertension [13] .
The aim of this study was to compare the mean platelet volume (MPV) in babies of preeclamptic and normal pregnant women and to investigate the correlation between thrombocytopenia and MPV in the babies of preeclamptic mothers.
Participants and methods
A total of 63 newborns with similar gestational age were included in this retrospective study who were followed up in Akdeniz University, Department of Neonatology, School of Medical Children Health and Diseases between the dates of 1 January 2009 and 31 December 2009. They were divided into three groups as 21 babies of preeclamptic mothers with thrombocytopenia (Group A), 21 without thrombocytopenia (Group B), and 21 babies of normal pregnant women without thrombocytopenia (Group C). Hematologic data of the patients, obtained in the first 72 h of their life, were achieved from their medical records. In the diagnosis of preeclampsia, medical history, obstetric examination, and laboratory tests were used and for the prognosis after the 20th week, the blood pressure checked at least twice in 6-h intervals higher than 140/90 mmHg or average arterial pressure higher than 105 mmHg, proteinuria higher than þ1 in spot urine or higher than 300 mg in 24 h were taken into consideration [14] . Participants were compared in a retrospective way according to their birth weights, platelet counts, and MPV. Platelet number and MPV values were determined by using the Beckman Coulter Co. Lh 780 Analyzer (Germany) device. Normal values of MPV were accepted as 6.5-11.6 fl. Platelet and MPV values checked in the first postnatal 72 h were used for the comparison. SPSS 10 software package program (SPSS Inc., Chicago, Illinois, USA) was used for the statistical analysis. Values were given as mean AE SD. Differences between groups were tested for significance by Mann-Whitney U-test and, analysis of variance (ANOVA) test, and Kruskal-Wallis tests. The relationship between variables was analyzed by Spearman's r correlation. Differences and correlations were considered significant at P less than 0.05.
Results
Mean gestational ages, birth weights, platelet numbers, and MPV values of the groups A, B, and C were given in Table 1 . When these three groups were compared to their platelet numbers, platelet number of the group A was found to be lower compared to groups B and C in a statistically significant way (P < 0.001). In comparison of MPV values, despite MPV value of group A being higher than the other groups, no statistically significant difference was detected between the groups (P ¼ 0.052). MPV value was shown to decrease as the platelet number increased. No statistically significant correlation between the platelet number and MPV value was found (P ¼ 0.171; R ¼ À0.175).
Discussion
The main deficiency in the preeclampsia pathogenesis is accepted as uteroplacental ischemia, and as a result of the damaged trophoblastic invasion of the maternal vessels, mediators that join circulation due to the decreased placental perfusion damage the endothelial cells and disrupt their functions. Thrombocytopenia occurring in preeclampsia is thought to be related to the increased consumption. Some studies claim that due to significant vasoconstriction of uteroplacental vessels, which include fibrin depots even in normal pregnancy, blood circulation in these vessels slows down significantly. Thrombocytopenia is the result of this residual thrombosis and platelet consumption [2, 15] .
There are also studies that examine the thrombocytopenia etiology in regard to the mediators. The data obtained from these studies support that in normal conditions, vascular endothelial growth factor (VEGF) and placental growth factor (PIGF) cause the maturation of megakaryocyte and participate in the Flt-1 (fms-like tyrosine kinase 1), which regulates megakaryocyte development. On the other hand, the construction of these two growth factors is decreasing in preeclampsia [16, 17] .
Upsizing in the volume of platelet is accepted as an indicator of increased platelet synthesis for a long time [3, 4] . It is well known that the higher MPV seen in normal pregnancies depends on the increased platelet formation [5, 6, 18, 19] . Despite this, researches made to compare the MPV and platelet numbers of the preeclamptic mothers with normal pregnancies have shown different results. Whereas some researchers did not find any statistically significant difference between preeclamptic women and control groups regarding platelet numbers and MPV values, others found lower platelet numbers and higher MPV values in preeclamptic women [20, 21] . On the other hand, Dundar et al. [22] compared preeclamptic women with normal pregnant women and showed a statistically significant increase in MPV levels just 4.6 weeks before the occurrence of preeclampsia symptoms. However, in contrast to these data, it was emphasized that MPV values may also be higher in normal pregnancies and just making a MPV screening test may be insufficient [18, 19] . In conclusion, the reason for thrombocytopenia occurring in preeclamptic mothers is still unknown.
Just like in preeclamptic women, the reason for thrombocytopenia occurring in the babies of the preeclamptic mothers is still unknown as well. According to our knowledge, there are only a few studies that have examined the reason behind thrombocytopenia in regard to whether it occurs due to the construction deficiency or excessive destruction. Meberg et al. [23] claimed that fetal hypoxia affects the multipotent stem cell in the bone marrow and causes an increase in erythropoiesis; as a result of this development, a decrease occurs in both megakaryopoiesis and myelopoiesis. Samuels et al. [24] have shown the abnormal platelet antibodies in the babies of preeclamptic mothers and they claimed the reason behind this development is an immune abnormality or a metric of platelet activation. On the other hand, thrombocytopenia could not be detected in any of the babies with abnormal test results. It was shown that the sFlt-1 level is higher and PIGF and VEGF levels are lower in the cordon blood of the babies of the preeclamptic mothers [25] .
We could not find even a single study in the literature about the relationship between thrombocytopenia and MPV in the babies of preeclamptic mothers. For this reason, according to our knowledge, our study is the first about the relationship between thrombocytopenia and MPV in the babies of preeclamptic mothers. According to our results, MPV seemed to increase as platelet counts decreased when the groups were compared.
However, no significant correlation was found between MPV and platelet counts and no significant difference between MPVs (P ¼ 0.052). Moreover, it should also be noted that MPV value is increasing as the mean platelet number decreases among groups (Group A platelet number: 113 AE 28 Â10 9 /LT and MPV: 7.94 AE 0.79 fl; Group B platelet number 258 AE 104 Â10 9 /LT and MPV: 7.83 AE 0.65 fl; Group C platelet number: 284 AE 106 Â10 9 /LT and MPV: 7.42 AE 0.67 fl). Despite no detection of statistical significance, the observations that MPV was highest in the babies with thrombocytopenia and that MPV increased with the decrease in platelets among the groups, made us think that thrombocytopenia seen in the babies of preeclamptic mother might be related to destruction of the platelets.
In conclusion, this study was made by screening MPV and platelet values belonging to babies of preeclamptic mothers from medical records in a retrospective way. We believe that it would be more helpful to the etiology if this study is repeated by including the thrombopoietin values of the babies of the preeclamptic mothers and platelet numbers, and MPV and thrombopoietin values of the mothers.
